Use of Hepatitis C Nucleic Acid Test–Positive Liver Allografts in Hepatitis C Virus Seronegative Recipients
Nadeem Anwar, Tiffany E. Kaiser, Khurram Bari, Michael Schoech, Tayyab S. Diwan, Madison C. Cuffy, Latifa Silski, Ralph C. Quillin, Kamran Safdar, Shimul A. Shah – 3 March 2020 – Because of underutilization of liver allografts, our center previously showed that hepatitis C virus (HCV) antibody–positive/nucleic acid test (NAT)–negative livers when transplanted into HCV nonviremic recipients were safe with a 10% risk of HCV transmission. Herein, we present our single‐center prospective experience of using HCV NAT+ liver allografts transplanted into HCV NAT– recipients.